NASDAQ:ACAD - ACADIA Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$26.19 +0.09 (+0.34 %)
(As of 03/26/2019 01:19 AM ET)
Previous Close$26.10
Today's Range$25.5307 - $26.68
52-Week Range$12.77 - $28.12
Volume918,323 shs
Average Volume1.60 million shs
Market Capitalization$3.77 billion
P/E Ratio-13.50
Dividend YieldN/A

Analyst Ratings

ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for ACADIA Pharmaceuticals in the last 12 months. Their average twelve-month price target is $32.60, suggesting that the stock has a possible upside of 24.47%. The high price target for ACAD is $60.00 and the low price target for ACAD is $17.00. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.602.75
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.60$31.70$31.70$39.8182
Price Target Upside: 24.47% upside74.08% upside74.08% upside102.53% upside

ACADIA Pharmaceuticals (NASDAQ:ACAD) Consensus Price Target History

Price Target History for ACADIA Pharmaceuticals (NASDAQ:ACAD)

ACADIA Pharmaceuticals (NASDAQ:ACAD) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/3/2019JPMorgan Chase & Co.Reiterated RatingBuyLowView Rating Details
2/28/2019Piper Jaffray CompaniesBoost Price TargetOverweight$30.00LowView Rating Details
2/27/2019Canaccord GenuityBoost Price TargetHold ➝ In-Line$23.00 ➝ $27.00HighView Rating Details
2/27/2019Cantor FitzgeraldReiterated RatingBuy$30.00HighView Rating Details
11/16/2018UBS GroupInitiated CoverageNeutral$39.00LowView Rating Details
11/12/2018Leerink SwannInitiated CoverageMarket Perform$21.00HighView Rating Details
11/1/2018HC WainwrightReiterated RatingBuy$60.00HighView Rating Details
10/10/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$22.00 ➝ $25.00HighView Rating Details
8/9/2018JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$50.00 ➝ $27.00HighView Rating Details
8/7/2018Stifel NicolausInitiated CoverageHold ➝ Hold$17.00LowView Rating Details
11/7/2017CowenReiterated RatingBuy$46.00N/AView Rating Details
10/12/2017Jefferies Financial GroupReiterated RatingBuy$47.00N/AView Rating Details
10/6/2017Goldman Sachs GroupReiterated RatingNeutral$45.00N/AView Rating Details
10/2/2017LADENBURG THALM/SH SHReiterated RatingBuy$48.00 ➝ $50.00LowView Rating Details
9/17/2017Needham & Company LLCReiterated RatingBuy$49.00LowView Rating Details
5/22/2017Rodman & RenshawReiterated RatingBuy$60.00LowView Rating Details
(Data available from 3/26/2017 forward)
This page was last updated on 3/26/2019 by Staff

Featured Article: Options Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel